Renato Tassi

The impact of sunitinib-induced hypothyroidism on progression-free survival of metastatic renal cancer patients: A prospective single-center study

Valentina Baldazzi, Renato Tassi, A. Lapini et al. · Urologic Oncology Seminars and Original Investigations · 2010 · 64 citations

Medicine, Endocrinology, Oncology +17

Biweekly sunitinib regimen reduces toxicity and retains efficacy in metastatic renal cell carcinoma: A single‐center experience with 31 patients

Bruno Neri, Agnese Vannini, Marco Brugia et al. · International Journal of Urology · 2012 · 49 citations · Full text

Medicine, Oncology, Pharmacology +13

RNA sequencing reveals <i>PNN</i> and <i>KCNQ1OT1</i> as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy

Enrico Mini, Andrea Lapucci, Gabriele Perrone et al. · International Journal of Cancer · 2019 · 34 citations · Full text

Medicine, Molecular Medicine, Oncology +17

HLA-G 3’UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment

Marica Garziera, Ettore Bidoli, Erika Cecchin et al. · PLoS ONE · 2015 · 33 citations · Full text

Life Sciences, Genetics, Oncology +17

Sunitinib‐induced hyperparathyroidism

Valentina Baldazzi, Renato Tassi, A. Lapini et al. · Cancer · 2011 · 23 citations · Full text

Medicine, Oncology, Pharmacology +16